Govorestat, First And Only Potential Treatment For Classic Galactosemia, Does Not Receive ...
We urge FDA to reconsider on behalf of those facing Galactosemia, their family members & future generations.
oncnursingnews9 天
FDA Approves Zanidatamab for Pretreated HER2-Positive Biliary Tract Cancer
The FDA granted an accelerated approval to zanidatamab-hrii for previously treated, unresectable or metastatic HER2-positve ...